Table 1 : Characteristics of the investigated patient cohort (N=380)*.


Characteristic Unit/Level Median (5th and 95th
percentile)/Proportion

Gender Male 56% --
Age Years 64.6 (46.6-74.8)
Diabetes  duration Years 9.0 (1.0-28.0)
BMI   kg/m² 30.6 (23.9-39.8)
HbA1c   % 7.2 (5.8-9.9)
HbA1c IFCC mmol/mol 55.2 (39.9-84.7)
Glycated albumin % 16.6 (12.3-24.2)
Cholesterol mg/dl 189.0 (125.0-270.0)
LDL–Cholesterol mg/dl 114.0 (61.0-174.0)
HDL–Cholesterol  mg/dl 47.0 (29.0-77.0)
Triglycerides mg/dl 140.0 (63.0-407.0)
Hemoglobin (males) g/dl 14.7 (12.5-16.9)
Hemoglobin (females) g/dl 13.5 (11.9-15.1)
hsCRP mg/l 2.5 (0.3-13.0)
NT-proBNP pg/ml 85.5 (14.0-790.0)
eGFR  ml/min 91.4 (50.0-146.9)
Urine albumin/creatinine ratio mg/g 15.1 (2.5-225.9)
Blood pressure systolic mmHg 143.0 (120.0-178.0)
Blood pressure diastolic  mmHg 80.0 (60.0-100.0)

Treatment   Prevalence (%)

Oral antidiabetic drugs (OAD)   54%
Insulin with/without
combination of OAD
  46%
Statins   47%
ACE-Inhibitors/AT1 blockers   72%
Diuretics   54%
Beta blockers   49%
Calcium antagonists   31%

Concomitant diseases   Prevalence (%)

Hypertension   88%
Coronary heart disease   19%
Cerebrovascular disease   11%
Peripheral arterial disease   20%
Neuropathy   45%
eGFR<60 ml/min   12%
Microalbuminuria   27%
Retinopathy (any degree)   19%

*Results apply to the first visit.

Hasslacher et al.Journal of Diabetes Research and Clinical Metabolism  2014 3:9DOI : 10.7243/2050-0866-3-9